PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 19.11.2019 at 4:00 PM CET
Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (EP1861075) COATED GRANULAR FORMULATIONS

Office : European Patent Office
Application Number: 06792448 Application Date: 15.03.2006
Publication Number: 1861075 Publication Date: 05.12.2007
Publication Kind : B1
Designated States: AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR
Prior PCT appl.: Application Number:EP2006060761 ; Publication Number: Click to see the data
IPC:
A61K 9/50
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
48
Preparations in capsules, e.g. of gelatin, of chocolate
50
Microcapsules
CPC:
A61K 31/7076
A61K 9/2013
A61K 9/2018
Applicants: GRAAL S R L
Inventors: SENECI ALESSANDRO
GIOVANNONE DANIELE
ZIO CESARE
Priority Data: 06792448 15.03.2006 EP
MI20050485 23.03.2005 IT
Title: (DE) BESCHICHTETE GRANULATFORMULIERUNGEN
(EN) COATED GRANULAR FORMULATIONS
(FR) FORMULATIONS GRANULAIRES REVETUES
Abstract:
(EN) A granular formulation is described, said formulation being based on granules formed by an inner core essentially consisting of at least one pure active component, mixtures of active components or mixtures thereof with suitable inert excipients or pharmaceutically acceptable salts thereof in an amount of between 50% and 90% by weight of the formulation, and by an outer coating essentially consisting of hydrogenated vegetable fats in an amount of between 10% and 50% by weight of the formulation. An example of the selected active component is S-adenosylmethionine. The product according to said formulation can be used, for example, also in the veterinary field for administration by mixing with the feed.
(FR) L'invention concerne une formulation granulaire à base de granules formée d'un noyau interne composé essentiellement d'au moins un composant actif pur, de mélanges de composants actifs ou de mélanges de ceux-ci avec des excipients inertes appropriés ou des sels de ceux-ci pharmaceutiquement acceptables selon une quantité comprise entre 50 et 90 % en poids de la formulation; et d'un revêtement extérieur composé essentiellement de graisses végétales hydrogénées selon une quantité comprise entre 10 % et 50 % en poids de la formulation. Un composant actif sélectionné pris en exemple est S-adénosylméthionine. Le produit obtenu selon la formulation peut être utilisé, par exemple, dans le domaine vétérinaire afin d'être administré par mélange avec les aliments.
Also published as:
US20080152765ES2384577WO/2007/003447